A Phase 4 Study to Evaluate the Effectiveness and Safety of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Clinical trial NCT07347938 · RECRUITING
Trial details
- NCT number
- NCT07347938
- Sponsor
- Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-01-14
- Primary completion
- 2028-12-31
- Enrollment
- 6000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.